| ALLIANCE |
Lynx gets deal with Pfizer Lynx Therapeutics Inc. of Hayward said Tuesday it has signed an agreement with Pfizer Inc. to study gene expression in cell samples. Specific financial details were not disclosed, but Lynx will receive payments for the genomics discovery services it performs on the samples provided by Pfizer. Under the agreement, Lynx will use its Massively Parallel Signature Sequencing, or MPSS, technology to study cell samples from normal and disease-affected patients in an effort to provide information on specific genes involved in disease progression. |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |